Physician profile
Tripti Burt
NPI 1336213032
$2,580.54
in general payments reported to CMS, 2019-2025
8 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $273 · 2021: $70.57 · 2022: $34.21 · 2023: $311 · 2024: $1,546 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,176 · Travel and Lodging: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.11 |
| Travel and Lodging | $859.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,022.56 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medical Device Business Services, INC. | $495.80 | 2024 | |
| Motiva USA, LLC | $432.64 | 2024-2025 | |
| Galderma Laboratories, L.P. | $372.23 | 2020-2025 | Dysport |
| Abbvie INC. | $142.76 | 2023 | Natrelle Saline-Filled Breast Implants |
| Pacira Pharmaceuticals Incorporated | $83.74 | 2019-2023 | Exparel |
| Smith+Nephew, INC. | $16.66 | 2019 | |
| Allergan, INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tripti Burt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.